Envista Holdings Corporation reported $2.86B of revenue over the trailing twelve months, +12% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.86B (to Q2 2026). Net income: $95M, trailing twelve months to Q2 2026. Free cash flow: $248M, trailing twelve months to Q2 2026. Operating margin: 9.6%, trailing twelve months to Q2 2026.

NVSTEnvista Holdings Corporation

Healthcare

$22.99+9.8% 1Y

$22.99

$18.9552 weeks$30.26

NVST as reported

Envista Holdings Corporation reported $2.86B of revenue over the trailing twelve months, +12% on the year before. 11 reported series are charted on this page, each one as filed.

$2.86B

Revenue, trailing twelve months · to Q2 2026 · +12% against the twelve months before

Net income: $95M
Net income · +77% year on year · trailing twelve months to Q2 2026
Free cash flow: $248M
Free cash flow · −3.8% year on year · trailing twelve months to Q2 2026
Operating margin: 9.6%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for NVST, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.86B	+12%	Q2 2026
Net income	$95M	+77%	Q2 2026
EPS	$0.58	+81%	Q2 2026
Gross margin	55%	n/a	Q2 2026
Operating margin	9.6%	n/a	Q2 2026
Net margin	3.2%	n/a	Q2 2026
ROE	1.8%	n/a	Q2 2026
ROA	1.0%	n/a	Q2 2026
ROIC	5.3%	n/a	Q2 2026
Free cash flow	$248M	−3.8%	Q2 2026
P/E	39.6	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.